Multiple Assemblies exist for SMTL entry 8ofa
Crystal structure of human cathepsin L interacting with tosyl phenylalanyl chloromethyl ketone (TPCK); X-RAY DIFFRACTION 1.90 Å

	SMTL ID 8ofa.1 Ligands N-[(2S)-4-chloro-3-oxo-1-phenyl-butan-2-yl]-4-methyl-benzenesulfonamide; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; DIMETHYL SULFOXIDE; TRIETHYLENE GLYCOL; 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE; 4-methyl-~{N}-[(2~{S})-4-oxidanyl-3-oxidanylidene-1-phenyl-butan-2-yl]benzenesulfonamide Polypeptides Cathepsin L Oligo-state monomer
	SMTL ID 8ofa.2 Ligands N-[(2S)-4-chloro-3-oxo-1-phenyl-butan-2-yl]-4-methyl-benzenesulfonamide; DI(HYDROXYETHYL)ETHER; 1,2-ETHANEDIOL; DIMETHYL SULFOXIDE; ACETATE ION Polypeptides Cathepsin L Oligo-state monomer
	SMTL ID 8ofa.3 Ligands N-[(2S)-4-chloro-3-oxo-1-phenyl-butan-2-yl]-4-methyl-benzenesulfonamide; DI(HYDROXYETHYL)ETHER; DIMETHYL SULFOXIDE; 1,2-ETHANEDIOL Polypeptides Cathepsin L Oligo-state monomer
	SMTL ID 8ofa.4 Ligands N-[(2S)-4-chloro-3-oxo-1-phenyl-butan-2-yl]-4-methyl-benzenesulfonamide; DI(HYDROXYETHYL)ETHER; DIMETHYL SULFOXIDE; 1,2-ETHANEDIOL; TRIETHYLENE GLYCOL; 4-methyl-~{N}-[(2~{S})-4-oxidanyl-3-oxidanylidene-1-phenyl-butan-2-yl]benzenesulfonamide Polypeptides Cathepsin L Oligo-state monomer